Treatment of short bowel syndrome patients with colon-in-continuity
US7847061B2 · kind B2 · utility
37Cited by
4References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 1, 2005 |
| Grant date | Dec 7, 2010 |
| Priority date | — |
| Expiry date | Nov 1, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.